% | $
Quotes you view appear here for quick access.

Geron Corporation Message Board

  • blackmarango blackmarango Feb 19, 2013 8:50 AM Flag

    Baker Brothers?

    If we can assume that the Baker Brothers have NO inside information, I know that this is a very big IF, a very interesting question arises!

    What do they know that ALL the big pharms don't know?????????????

    The big pharms have been following GERN for 10-12 years, so they know what is going on.

    The big phams have HUGE research labs just looking for the next big drug!

    Any one of the big pharms could buy GERN with their petty cash!

    So, just what do the Baker's know that the rest of the world doesn't????????????

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • They know the same we know. Geron was a value in the 4th qtr of 2012. Imetelstat data is good and the co is very likely to be bought out

      Sentiment: Strong Buy

    • WOW, this has been a very interesting thread!!!

      I was just looking at my charts and one of my stochastic screens shows GERN almost oversold while the other one shows it almost overbought. I don't ofter see this. The two sets of parametrics usual track one another very well.

      At $1.52, and with the current 163L results, GERN just may be an interesting "risk" trade.

    • I did a little research in to the Baker bros. They are in the top ten best performing hedge funds for 2012. They focus almost exclusively on biotech. They buy at the bottom (4th qrt GERN hit an all time low). They are long term holders. Typically 3 years. Their picks usually get bought out by large pharma. They are very secretive and do NOT do interviews. Lots of traders follow them through the fund's quarterly filings. It appears that these guys know what they are doing to such an extent that many traders and biotech analysts are watching them very closely.

      Sentiment: Strong Buy

    • You don't need to know anything special. everything is already in the data. response could be meaured objectively bacause of the genetic marker. Response was robust and sustainable (over a year). There are 70-75 thou ET patients in US alone, and this seems to be a great med for them. I bought some GERN.

2.85+0.04(+1.42%)May 27 4:00 PMEDT